1.Scintigraphic Analysis of Left Ventricular Diastolic Function in Coronary Artery Disease.
Eun Seok JEON ; Deok Kyung KIM ; Byung Hee OH ; June Key CHUNG ; Myoung Mook LEE ; Young Bae PARK ; Jung Don SEO ; Young Woo LEE ; Chang Soon KOH
Korean Circulation Journal 1987;17(2):289-298
To evaluate left ventricular diastolic function in patients with coronary artery disease, gate radionuclide ventriculography was performed prospectively in 42 patients who were admitted to Seoul National University Hospital from November 1985 to August 1986 because of anterior chest pain. All patients had no valvular heart disease, congenital heart disease, cardiomyopathy and arrhythmia, and no abnormal vall motion in gated nuclide ventriculography and contrast left ventriculography. 25 patients with more than 50% of stenosis in coronary arteriography were compared with 17 control subjects without stenosis. The following results were obtained; 1) There were no significant differences between normal controls and patients with coronary artery disease in the analysis of the parameters of the left ventricular systolic function, such as ejection fraction (EF), peak ejection rate (PER), time to peak ejection rate (TPER) and ejection time (TES, TES/BCL). 2) Same results were found with those of the left vnetricular diastolic function, such as peak filling rate (PFR), diastolic time interval (DTI, DTI/BCL), rapid diastolic filling interval and time to late diastolic filling (TLDF). 3) The percent contribution of late diastolic filling to stroke volume (%LDF/SV) was more increased in patients with coronary artery disease than the normal control subjects (38.2+/-12.4% vs 28.3+/-7.8%, P<0.01). 4) As the results of above, it can be concluded that the percent contribution of late diastolic filling to stroke volume (%LDF/SV) obtained by using the non-invasive method of gated radionuclide ventriculography can be a sensitive parameter for early evaluation of the left ventricular diastolic dysfunction in coronary artery disease.
Angiography
;
Arrhythmias, Cardiac
;
Cardiomyopathies
;
Chest Pain
;
Constriction, Pathologic
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Gated Blood-Pool Imaging
;
Heart Defects, Congenital
;
Heart Valve Diseases
;
Humans
;
Prospective Studies
;
Radionuclide Ventriculography
;
Seoul
;
Stroke Volume
2.Pred ictive Efficacy of Radioisotope Voiding Cystography for Renal Outcome.
Yu Kyeong KIM ; June Key CHUNG ; Seok Ki KIM ; Jung Seok YEO ; Dong Soo LEE ; Bo Youn CHO ; Jae Min JEONG ; Myung Chul LEE
Korean Journal of Nuclear Medicine 2000;34(2):135-143
PURPOSE: As vesicoureteral reflux (VUR) could lead to renal functional deterioration when combined with urinary tract infection, we need to decide whether operative anti-reflux treatment should be performed at the time of diagnosis of VUR. Predictive value of radioisotope voiding cystography (RIVCG) for renal outcome was tested. MATERIALS AND METHODS: In 35 children (18 males, 17 females), radiologic voiding cystourethrography (VCU), RIVCG and DMSA scan were performed. Change in renal function was evaluated using the follow-up DMSA scan, ultrasonography, and clinical information. Discriminant analysis was performed using individual or integrated variables such as reflux amount and extent at each phase of voiding on RIVCG, in addition to age, gender and cortical defect on DMSA scan at the time of diagnosis. Discriminant function was composed and its performance was examined. RESULTS: Reflux extent at the filling phase and reflux amount and extent at postvoiding phase had a significant prognostic value. Total reflux amount was a composite variable to predict prognosis. Discriminant function composed of reflux extent at the filling phase and reflux amount and extent at postvoiding phase showed better positive predictive value and specificity than conventional reflux grading. CONCLUSION: RIVCG could predict renal outcome by disclosing characteristic reflux pattern during various voiding phases.
Child
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Male
;
Prognosis
;
Sensitivity and Specificity
;
Succimer
;
Ultrasonography
;
Urinary Tract Infections
;
Vesico-Ureteral Reflux
3.Results of Radioiodine Treatment for Distant Metastases of Differentiated Thyroid Carcinoma.
Yu Kyeong KIM ; June Key CHUNG ; Seok Ki KIM ; Jung Seok YEO ; Do Joon PARK ; Jae Min JEONG ; Dong Soo LEE ; Bo Youn CHO ; Myung Chul LEE
Korean Journal of Nuclear Medicine 2000;34(2):107-118
PURPOSE: To evaluate the effectiveness of radioiodine treatment for metastatic thyroid carcinoma, we reviewed results of radioactive iodine treatment in patients with functional lung or bone metastases. MATERIALS ANF METHODS: Of 760 patients who were treated for differentiated thyroid cancer between 1984 and 1998, we detected pulmonary metastases and bone metastases in 76 patients (10.0%) and 20 patients (2.6%), respectively. Among them, we could evaluate the effectiveness of I-131 therapy in 53 patients with lung metastases and 15 patients with bone metastases. RESULTS:Of 53 patients who received I-131 therapy with a mean cumulative dose of 26.2 GBq (1.1-84.4 GBq) for pulmonary metastases, metastatic lung lesions completely resolved in 19 patients (35.8%) and improved in 22 patients (41.5%). In 13 of 19 patients with complete remission of pulmonary metastases, the total accumulated dose of I-131 was less than 18.5 GBq. We found 43 sites of metastatic bone lesions in 15 patients with bone metastases. Of 29 lesions which received I-131 therapy, metastatic lesions improved in 14 sites (48.3%), but did not change or progress in 15 sites (51.7%) despite the I-131 therapy. Three lesions were completely cured with a combination treatment of surgery(+/- external radiotherapy) and I-131 therapy, and the other 11 lesions improved. CONCLUSION: Radioactive iodine treatment gives favorable results for pulmonary metastases. However, for bone metastases, there might be a need to use combination therapy including I-131 and surgery or external irradiation.
Atrial Natriuretic Factor
;
Humans
;
Iodine
;
Lung
;
Neoplasm Metastasis*
;
Thyroid Gland*
;
Thyroid Neoplasms*
4.Bone Scan Appearance of Renal Osteodystrophy in Diabetic Chronic Renal Failure Patients.
Young SO ; Dong Soo LEE ; In Yong HYUN ; Won Jun KANG ; Won Woo LEE ; June Key CHUNG ; Suhng Gwon KIM ; Myung Chul LEE ; Jung Sang LEE ; Chang Soon KOH
Korean Journal of Medicine 1997;53(2):216-224
OBJECTIVES: It is suggested that frequency of low turnover bone disease is much higher in diabetic renal osteodystrophy. We tried to find out whether bone scan images show less 99mTc-MDP uptake in diabetic renal ostwdystrophy. METHODS: We compared bone scan images of renal failure patients with and without diabetes. The number of patients studied was 134 (43 patients had diabetes and 91 patients did not). Two experienced nuclear physicians read Tc-99m-MDP bone scan twice separately and gave the score either 1 or 0 on 6 areas; axial skeleton, long bone, skull and mandible, periarticular areas, costochondral junction and sternum. The means of summed scores were compared using Students t-test. To exclude the effects of sex, age and serum creatinine concentration, we analysed these factors together with the effect of diabetes using analysis of covariance. We also interpreted on bone scan images, as classical renal osteodystrophy, renal failure and normal. RESULTS: The intra- and interobserver variations were very low. Patients of diabetes group showed significantly lower mean of summed score(2.0+/-0.95) compared to patients of non-DM group(3.3+/-1.2). Analysis of covariance revealed that lower score of diabetes group was independent of sex, age and serum creatinine level. of diabetes group, 2 nuclear physicians interpreted bone scans as classical renal osteodystrophy in 60% and 56%, However, they interpreted bone scans of non-DM group in 80%, 88%(between-observer k: 0.74). Chi-square test showed that this difference was statistically significant (p<0.05). CONCLUSION: Bone scan image of diabetic renal osteodystrophy showed less 99mTc-MDP uptake, which meant low osteoblastic activity. This influence of diabetes upon bone uptake was significant after considering other confounding factors.
Bone Diseases
;
Creatinine
;
Diabetes Mellitus
;
Humans
;
Kidney Failure, Chronic*
;
Mandible
;
Observer Variation
;
Osteoblasts
;
Renal Insufficiency
;
Renal Osteodystrophy*
;
Skeleton
;
Skull
;
Sternum
;
Technetium Tc 99m Medronate
5.Scintigraphic Analysis of Left Ventricular Diastolic Filling in Patients with Angina Pectoris before and after Percutaneous Transluminal Coronary Angioplasty.
Eun Seok JEON ; Byung Hee OH ; June Key CHUNG ; Myung Chul LEE ; Myoung Mook LEE ; Young Bae PARK ; Jung Don SEO ; Young Woo LEE ; Chang Sun KOH
Korean Circulation Journal 1990;20(1):77-88
Left ventricular(LV) diastolic filling is abnormal at rest in many patients with coronary arery disease, even in the presence of normal resting LV systolic function. To determine the effects of improved myocardial perfusion on impaired LV diastolic filling and to detect the most sensitive parameter to assess LV diastolic function, gated radionuclide ventriculography were performed in 14 patients with coronary artery disease before and after successful percutaneous transluminal coronary angioplasty(PTCA). All patients had no previous myocardial infarction and no abnormal wall motion in gated radionuclide and contrast ventriculography. The following results were obtained; 1) There were no significant differences in the parameters of LV systolic function, such as peak ejection rate(PER, time to peak ejection rate(TPER), ejection fraction(EF) after successful PTCA. 2) Peak filling rate(PFR) and time to peak filling rate(TPFR), indexes of LV diastolic function, had no significant changes after successful PTCA. 3) The percent contribution of late diastolic filling to stroke volume(%LDF/SV) decreased from 26.5+/-6.8% to 19.1+/-6.6%(p<0.005 by paired t-test). These data suggest that in many patients with angina and normal LV systolic function, impaired global diastolic filling is a reversible manifestation of impaired coronary flow, and percent contribution of late diastolic filling to stroke volume(%LDF/SV) can be a sensitive parameter to evaluate impaired LV diastolic filling in coronary artery disease.
Angina Pectoris*
;
Angioplasty, Balloon, Coronary*
;
Coronary Artery Disease
;
Gated Blood-Pool Imaging
;
Humans
;
Myocardial Infarction
;
Perfusion
;
Radionuclide Ventriculography
;
Stroke
6.Evaluation of various cardiac indices and ROC analysis in coronary artery disease employing resting ECG gated blood pool scan.
Chang Woon CHOI ; Dong Soo LEE ; Sang Eun KIM ; June Key CHUNG ; Myung Chul LEE ; Young Bae PARK ; Jung Don SEO ; Young Woo LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1992;26(1):40-48
No abstract available.
Coronary Artery Disease*
;
Coronary Vessels*
;
Electrocardiography*
;
ROC Curve*
7.Thallium-201 SPECT imaging of brain tumors.
Sang Eun KIM ; Chang Woon CHOI ; Dong Soo LEE ; June Key CHUNG ; Myung Chul LEE ; Chang Soon KOH ; Byung Woo YOON ; Jae Kyu ROH ; Hee Won JUNG
Korean Journal of Nuclear Medicine 1992;26(1):14-25
No abstract available.
Brain Neoplasms*
;
Brain*
;
Tomography, Emission-Computed, Single-Photon*
8.99mTc-HMPAO labelled WBC scan in experimental abscess by labelling autologous leukocu\ytes with in-house-synthesized HMPAO.
Dong Soo LEE ; Hyung Sik SHIN ; Curie AHN ; June Key CHUNG ; Myung Chul LEE ; Kang Won CHOI ; Chang Soon KOH ; Jae Min JUNG ; Eun Ju CHUNG
Korean Journal of Nuclear Medicine 1991;25(2):252-258
No abstract available.
Abscess*
;
Technetium Tc 99m Exametazime*
9.Evaluation of bone metastasis by 99mTc-MDP scan in stomach cancer patients.
Chang Woon CHOI ; Sang Eun KIM ; Dong Soo LEE ; Jung Seok LYEO ; Curie AHN ; June Key CHUNG ; Myung Chul LEE ; Noe Kyung KIM ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1991;25(2):211-218
No abstract available.
Humans
;
Neoplasm Metastasis*
;
Stomach Neoplasms*
;
Stomach*
;
Technetium Tc 99m Medronate*
10.Lung/Heart uptake ratio in dipyridamole Tc-MIBI myocardial perfusion scan in coronary artery disease.
Keon Wook KANG ; Dong Soo LEE ; Chang Woon CHOI ; Kyung Han LEE ; June Key CHUNG ; Myung Chul LEE ; Jung Don SEO ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1993;27(2):218-222
No abstract available.
Coronary Artery Disease*
;
Coronary Vessels*
;
Dipyridamole*
;
Perfusion*